These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 9508381

  • 1. Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study.
    Reali UM, Martini L, Borgognoni L, Semino C, Pietra G, Chiarugi C, Guastella M, Melioli G.
    Melanoma Res; 1998 Feb; 8(1):77-82. PubMed ID: 9508381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L, Helmbold P, Emmert S, Marsch WC.
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [Abstract] [Full Text] [Related]

  • 7. Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group.
    Queirolo P, Ponte M, Gipponi M, Cafiero F, Peressini A, Semino C, Pietra G, Lionetto R, Vecchio S, Ribizzi I, Melioli G, Sertoli MR.
    Ann Surg Oncol; 1999 Aug; 6(3):272-8. PubMed ID: 10340886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
    de Hullu JA, Hollema H, Hoekstra HJ, Piers DA, Mourits MJ, Aalders JG, van der Zee AG.
    Cancer; 2002 Jan 15; 94(2):486-91. PubMed ID: 11905414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R.
    J Clin Oncol; 2006 Jul 01; 24(19):3157-63. PubMed ID: 16809738
    [Abstract] [Full Text] [Related]

  • 14. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 01; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 15. Combined-modality therapy for patients with regional nodal metastases from melanoma.
    Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):106-13. PubMed ID: 16182463
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
    Gibbs P, Anderson C, Pearlman N, LaClaire S, Becker M, Gatlin K, O'Driscoll M, Stephens J, Gonzalez R.
    Cancer; 2002 Jan 15; 94(2):470-6. PubMed ID: 11900232
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.
    Ridolfi L, Ridolfi R, Riccobon A, De Paola F, Petrini M, Stefanelli M, Flamini E, Ravaioli A, Verdecchia GM, Trevisan G, Amadori D.
    J Immunother; 2003 Jan 15; 26(2):156-62. PubMed ID: 12616107
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
    Lacreusette A, Lartigue A, Nguyen JM, Barbieux I, Pandolfino MC, Paris F, Khammari A, Dréno B, Jacques Y, Blanchard F, Godard A.
    J Pathol; 2008 Dec 15; 216(4):451-9. PubMed ID: 18798220
    [Abstract] [Full Text] [Related]

  • 20. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP, Hayes AJ, Thomas JM.
    ANZ J Surg; 2008 Nov 15; 78(11):982-6. PubMed ID: 18959697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.